ATRIAL FIBRILLATION DUE TO ORAL METHYLPREDNISOLONE IN A PATIENT WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS

: Cardiac adverse effects of intravenous pulse methylprednisolone administration are well known, but there is little information about the cardiac side effects of oral methylprednisolone in the literature. We present a 41 year-old man with membranoproliferative glomerulonephritis in whom developed atrial fibrillation after oral methylprednisolone therapy.